News|Articles|May 1, 2025

Psychiatry Month in Review: April 2025

Recent psychiatry updates reveal setbacks and breakthroughs in treatment, including Cobenfy's trial results, evolving patient-provider dynamics, and rising binge drinking among young women.

Recent developments in psychiatry highlight both setbacks and emerging opportunities in treatment. Cobenfy (xanomeline-trospium) fell short in a phase 3 trial as an adjunctive schizophrenia therapy, though safety and subgroup findings point to future potential. Survey data revealed a disconnect between patient and provider preferences for long-acting antipsychotics, and another stressed the need for improved adherence strategies.